Highest-materiality recent filing
TaoWeave invests $1M in Manako Labs, secures North America AI commercialization role
Invested $1M in UK-based Manako Labs for AI-powered computer vision platform.
TaoWeave invested $1M via SAFE in Manako Labs, gaining exclusive North American rights to Score AI platform on Bittensor Subnet 44.
TaoWeave returns to Q1 net income of $1.7M on $2.2M TAO gain; revenue up 14%
Net income $1.7M ($0.43 diluted EPS) vs net loss $0.7M ($0.59 loss) in Q1 2025; reflects $2.2M unrealized gain on TAO.
Stockholders reject TaoWeave redomestication to Nevada; equity plan passes
Redomestication to Nevada failed: 909,093 for (majority of votes cast) but not majority of 3,207,210 outstanding shares required.
Oblong Q3 revenue $0.6M, net loss $2.3M; TAO treasury grows to 21,822 tokens
Revenue of $0.6M (+4% YoY); net loss of $2.3M includes $1.5M unrealized loss on TAO revaluation.
Invested entire $7M from recent fundraise into TAO, the Bittensor token; now holds over 21,700 TAO actively staked.
Oblong Q2 2025 net loss narrows to $0.6M; TAO treasury expanded to 21,613 tokens ($8.0M investment)
Revenue of $0.6M flat YoY; net loss improved to $0.6M from $1.0M in Q2 2024.
Oblong deploys $8M in staked $TAO, forms Advisory Committee with $TAO expert Siam Kidd
Oblong invested $8M in Bittensor ($TAO) tokens, fully staked with a main validator to earn yields and support the network.
Oblong buys $1.65M in $TAO tokens, now holds 9,963 staked tokens on Bittensor
Acquired 4,938 $TAO tokens for $1.65M; total holdings now 9,963 tokens at avg $331/token.
Oblong acquires 5,025 $TAO tokens for $1.65 million to bolster decentralized AI strategy
Oblong Inc. (Nasdaq: OBLG) acquired 5,025 Bittensor ($TAO) tokens for $1.65 million using proceeds from $7.5 million June 2025 financing.
Oblong raises ~$7M in private placement to fund AI/digital asset strategy focused on Bittensor TAO
Private placement of ~1.99M shares/pre-funded warrants at $3.77/share, closing June 11, 2025.
Oblong Q1 2025 net loss narrows to $0.7M; cash $4.3M, no debt
Revenue flat at $0.6M; net loss improved from $1.1M to $0.7M YoY.
Oblong authorizes $500K stock buyback, up to ~25% of outstanding shares
Board authorized stock repurchase program for up to $500,000; could repurchase ~25% of ~1.1M outstanding shares at current prices.
Oblong Q4 2024 revenue down to $0.6M; net loss $0.9M; exploring M&A or asset sale
Q4 2024 total revenue $0.6M vs $0.9M in Q4 2023; net loss $0.9M vs $1.2M.
Oblong Q3 revenue falls 33% to $0.6M; net loss widens to $1.0M; exploring M&A
Revenue $0.6M in Q3 2024, down from $0.9M in Q3 2023; net loss $1.0M vs $0.9M.
Oblong regains Nasdaq minimum bid price compliance; holds $5.9M cash, no debt
Nasdaq notified Oblong it regained compliance with the $1.00 minimum bid price rule after 10 consecutive trading days above $1.00.
Oblong announces 1-for-40 reverse stock split to meet Nasdaq listing standards
Reverse split effective Aug 23, 2024 at 5 PM ET; split-adjusted trading starts Aug 26.
Oblong reports 38% increase in share count since Q1; raises ~$1.5M from warrant exercises
As of June 10, 2024, common shares outstanding rose to 27.96M from 20.29M on May 8, 2024.
Dwellwell securityholders would own 67% of combined equity; Oblong holders own 33%, on fully diluted basis.
Oblong common shares outstanding rise 19% to 24.2M as of May 28, 2024
Common shares outstanding: 24,169,253 on May 28, up from 20,285,675 on May 8, 2024.
Oblong issues 3.6M shares upon Series F preferred conversion, 21.6% dilution over two days
From March 19-20, 2024, 3,602,103 common shares issued upon conversion of 922 Series F Preferred shares.
Oblong Q4 2023 revenue down 36% YoY to $0.9M; net loss flat; exploring strategic alternatives
Q4 revenue $0.9M (down 36% YoY from $1.4M); net loss unchanged at $1.2M.
Oblong issues 9.2M shares in 3 days on Series F preferred conversions
Common shares outstanding jumped from 6.0M (Oct 10) to 15.2M (Oct 13), a 152% increase.
Oblong sets floor price of $0.2792 for preferred conversion and warrant exercise; issues 1.1M shares
Floor price for Series F preferred conversion and common warrant exercise set at $0.2792, with adjustments for stock splits.
Oblong issues ~997K shares on Series F conversion; common shares up 25%
Common shares outstanding: 4,913,260 as of Oct 3, 2023, up from 3,916,294 on Sep 13, 2023.
Nasdaq notified Oblong that its common stock closing bid price was below $1.00 for 30 consecutive business days.
Oblong common shares outstanding up 44% since June 30 on preferred conversions
Common shares outstanding rose from 2,728,928 (Jun 30) to 3,916,294 (Sep 12, 2023), a 44% increase.
Oblong reduces warrant exercise price to $1.71, inducing cash exercise of 339,498 shares
Warrant exercise prices reduced from $60-$82.35 to $1.71 per share for holders exercising 339,498 shares.
Oblong raises ~$6.4M via private placement of Series F convertible preferred and warrants
Gross proceeds $6,386,250; $4M held in escrow pending stockholder approval for share issuance.
Oblong regains compliance with Nasdaq minimum bid price requirement, delisting matter closed
Received written notice from Nasdaq on January 18, 2023 confirming compliance with Listing Rule 5550(a)(2).
Oblong effects 1-for-15 reverse stock split to meet Nasdaq listing standards
Reverse stock split ratio 1-for-15 effective 5:00 PM ET Jan 3, 2023; shares trade split-adjusted Jan 4 under OBLG.
Oblong Q3 revenue $1.2M (-33% YoY); net loss $7.2M on $5.2M impairment
Revenue $1.2M vs $1.8M in Q3 2021, down 33%.
Oblong gets 180-day Nasdaq extension to meet $1.00 bid price by Feb 13, 2023
Nasdaq granted a 180-day extension until Feb 13, 2023 to regain minimum bid price compliance.
Oblong Q2 revenue down 35% to $1.3M; net loss of $9.0M includes $6.4M impairment
Revenue $1.3M vs $2.0M in Q2 2021; net loss $9.0M vs $2.2M loss a year ago.
Oblong Q1 rev $1.5M (-21% YoY); net loss $4.5M; strategic review underway
Total revenue $1.5M vs $1.9M in Q1 2021, down 21% YoY.
On May 29, 2023, upon the recommendation of such lead investor and the approval of the Nominating Committee, the Board appointed Jonathan Schechter and Robert Weinstein as directors of the Company to fill the vacancies created by the resignation of Messrs. Lusk and Blumberg.
On May 28, 2023, each of James Lusk and Matthew Blumberg submitted to the Board a notice of resignation as a director of the Company, with such resignation to be effective immediately.
On May 29, 2023, upon the recommendation of such lead investor and the approval of the Nominating Committee, the Board appointed Jonathan Schechter and Robert Weinstein as directors of the Company to fill the vacancies created by the resignation of Messrs. Lusk and Blumberg.
On May 28, 2023, each of James Lusk and Matthew Blumberg submitted to the Board a notice of resignation as a director of the Company, with such resignation to be effective immediately.
On March 4, 2022, Pete Hawkes was terminated as the Senior Vice President of Product, Design & Engineering of Oblong, Inc., (the “Company”) due to the elimination of his position with the Company.
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.
Max materiality 0.80 · Median 0.65 · Most common event other_material